Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Naltrexone as an Antipruritic Agent for Surgical Scar Pruritus.
P2X4 Drives Sex-Specific neuroprotection in autoimmune neuroinflammation.
Understanding late-stage clinical trial failure in multiple sclerosis: insights from ClinicalTrials.gov.
Comment on "Spinal cord metabolism in multiple sclerosis: a decade of missed opportunities and future directions".
What Is the Potential Relevance of Hippocampal Area CA2 in Neurologic Disorders?
Extracellular HSPA5/Grp78/BiP, acting through its receptor Plexin-B3 and Nkx2.8, regulates oligodendrocyte myelination in mice.
Amyotrophic lateral sclerosis and chronic inflammatory demyelinating polyneuropathy coexistence in a patient with a C9orf72 variant: case report.
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.
Advances in nanotechnology for the diagnosis and management of autoimmune diseases.
Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes.
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity.
No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Association of elevated asymmetric dimethylarginine (ADMA) with subclinical carotid atherosclerosis in multiple sclerosis: A cross-sectional biomarker study.
Immune-metabolic trajectories delineate subgroups in paediatric long COVID.
The oxidative stress-inflammation self-perpetuating cycle in multiple sclerosis: from mechanisms to emerging antioxidant strategies.
Acupuncture for the treatment of Delayed Encephalopathy after Acute Carbon Monoxide Poisoning: a case report.
Multimodal machine learning for distinguishing pediatric multiple sclerosis from non-inflammatory conditions using optical coherence tomography.
Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis.
Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
Eye movement analysis during working memory tasks correlates with cognitive, clinical, and anatomical metrics in multiple sclerosis.
Unveiling the Clinical Impact of Lower Limb Robotic Devices in Neurorehabilitation: An Umbrella Review.
Rare adverse events after COVID-19 vaccination among Swedish older adults-evidence from a nationwide register-based study.
The clinical significance of S100B, APP, and CHI3L1 in autoimmune GFAP astrocytopathy.
The p.(Leu97Ile) variant expands the genetic landscape of NEFL-associated Charcot-Marie-tooth neuropathies.
Neurocysticercosis by Taenia sp. in a female alpaca (Vicugna pacos) from Germany.
Pages
« first
‹ previous
…
985
986
987
988
989
990
991
992
993
…
next ›
last »